comparemela.com

Page 2 - Adult Respiratory Syncytial Virus Rsv Infection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Moderna Says RSV Vaccine 84% Effective at Preventing Symptoms in Older Adults

Moderna said on Tuesday that its experimental mRNA vaccine for respiratory syncytial virus was 83.7% effective in a late-stage trial at preventing at least two symptoms, such as cough and fever, in adults aged 60 and older.

United statesNew yorkPatrick wingroveLeroy leoJulie steenhuysenTyler van burenStephen hogeCaroline humerEuropean commissionDrug administrationAstrazeneca plcPfizer incModerna incTyler vanMariame sunnyBill berkrot

Flu, COVID-19 Spreading as RSV Tails Off, CDC Says

This could be a rough season for respiratory infections even as the spread of respiratory syncytial virus seems to be calming down.

United statesRochelle walenskySandra fryhoferCenters for diseaseAmerican medical associationDepartment of healthHuman servicesDisease controlRespiratory infectionsRespiratory syncytial virus infectionAdult respiratory syncytial virus rsv infectionAdult respiratory syncytial virus rsv infectionDult respiratory syncytial virus rsvDult rsv infection019 novel coronavirus019 ncov

vimarsana © 2020. All Rights Reserved.